{"success":true,"data":{"pressRelease":{"id":"47565","rtpr_id":"nBw7btcV8a","ticker":"MRK","exchange":"NYSE","all_tickers":["MRK"],"title":"Merck to Participate in the Jefferies Global Healthcare Conference","author":"Business Wire","published_at":"2026-05-28T10:45:00.095Z","article_body":"Merck to Participate in the Jefferies Global Healthcare Conference\n\nMerck (NYSE: MRK), known as MSD outside of the United States and Canada,\nannounced today that Dr. Marjorie Green, senior vice president and head of\noncology, global clinical development, Merck Research Laboratories, is\nscheduled to participate in a fireside chat at the Jefferies Global Healthcare\nConference on Thursday, June 4, 2026, at 10:30 a.m. ET.\n\nInvestors, analysts, members of the media and the general public are invited\nto listen to a live audio webcast of the presentation at this weblink\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fevent.summitcast.com%2Fview%2FNgCqua4VVQjq9ibVWHVWca%2FcpwJoJai4zfVTMG46iL7VW&esheet=54542772&newsitemid=20260528272528&lan=en-US&anchor=weblink&index=1&md5=c65caeb13de5fc26587436480cf6784c)\n.\n\nAbout Merck\n\nAt Merck, known as MSD outside of the United States and Canada, we are unified\naround our purpose: We use the power of leading-edge science to save and\nimprove lives around the world. For more than 130 years, we have brought hope\nto humanity through the development of important medicines and vaccines. We\naspire to be the premier research-intensive biopharmaceutical company in the\nworld – and today, we are at the forefront of research to deliver innovative\nhealth solutions that advance the prevention and treatment of diseases in\npeople and animals. We foster a diverse and inclusive global workforce and\noperate responsibly every day to enable a safe, sustainable and healthy future\nfor all people and communities. For more information, visit www.merck.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.merck.com%2F&esheet=54542772&newsitemid=20260528272528&lan=en-US&anchor=www.merck.com&index=2&md5=0641a1ea5ba385c81c0b43154c0144a8)\nand connect with us on X (formerly Twitter)\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Ftwitter.com%2FMerck&esheet=54542772&newsitemid=20260528272528&lan=en-US&anchor=X+%28formerly+Twitter%29&index=3&md5=a5c378156f205649560539a3821f8cda)\n, Facebook\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.facebook.com%2FMerckInvents%2F&esheet=54542772&newsitemid=20260528272528&lan=en-US&anchor=Facebook&index=4&md5=a37e89aeddac05e8d303e81e677095b1)\n, Instagram\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.instagram.com%2Fmerck%2F&esheet=54542772&newsitemid=20260528272528&lan=en-US&anchor=Instagram&index=5&md5=b211c13080ddfd46d0a7ed50132a8c31)\n, YouTube\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.youtube.com%2FMerck&esheet=54542772&newsitemid=20260528272528&lan=en-US&anchor=YouTube&index=6&md5=ef9ae5dc856d12d63c06d1436aa8c475)\nand LinkedIn\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fmerck&esheet=54542772&newsitemid=20260528272528&lan=en-US&anchor=LinkedIn&index=7&md5=b16cb569273c32b5e7831b416dd98290)\n.\n\nForward-Looking statement of Merck & Co., Inc., Rahway, N.J., USA\n\nThis news release of Merck & Co., Inc., Rahway, N.J., USA (the\n“company”) includes “forward-looking statements” within the meaning of\nthe safe harbor provisions of the U.S. Private Securities Litigation Reform\nAct of 1995. These statements are based upon the current beliefs and\nexpectations of the company’s management and are subject to significant\nrisks and uncertainties. If underlying assumptions prove inaccurate or risks\nor uncertainties materialize, actual results may differ materially from those\nset forth in the forward-looking statements.\n\nRisks and uncertainties include but are not limited to, general industry\nconditions and competition; general economic factors, including interest rate\nand currency exchange rate fluctuations; the impact of pharmaceutical industry\nregulation and health care legislation in the United States and\ninternationally; global trends toward health care cost containment;\ntechnological advances, new products and patents attained by competitors;\nchallenges inherent in new product development, including obtaining regulatory\napproval; the company’s ability to accurately predict future market\nconditions; manufacturing difficulties or delays; financial instability of\ninternational economies and sovereign risk; dependence on the effectiveness of\nthe company’s patents and other protections for innovative products; and the\nexposure to litigation, including patent litigation, and/or regulatory\nactions.\n\nThe company undertakes no obligation to publicly update any forward-looking\nstatement, whether as a result of new information, future events or otherwise.\nAdditional factors that could cause results to differ materially from those\ndescribed in the forward-looking statements can be found in the company’s\nAnnual Report on Form 10-K for the year ended December 31, 2025 and the\ncompany’s other filings with the Securities and Exchange Commission (SEC)\navailable at the SEC’s Internet site (www.sec.gov\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.sec.gov&esheet=54542772&newsitemid=20260528272528&lan=en-US&anchor=www.sec.gov&index=8&md5=15d86724c9c3c34bf5a1f09bb8cea0bb)\n).\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260528272528/en/\n(https://www.businesswire.com/news/home/20260528272528/en/)\n\nMedia Contacts:\n\n\n\nJohn Cummins\n\njohn.cummins2@merck.com \n(mailto:john.cummins2@merck.com) \n\n\nMichael Levey\n\nmichael.levey@merck.com (mailto:michael.levey@merck.com)\n\nInvestor Contacts:\n\n\n\nPeter Dannenbaum\n\n(732) 594-1579\n\n\n\nSteven Graziano\n\n(732) 594-1583\n\n\nCopyright Business Wire 2026","article_body_html":"","raw_payload":{"data":{"id":"nBw7btcV8a","title":"Merck to Participate in the Jefferies Global Healthcare Conference","author":"Business Wire","ticker":"MRK","created":"2026-05-28T10:45:00.095Z","tickers":["MRK"],"exchange":"NYSE","article_body":"Merck to Participate in the Jefferies Global Healthcare Conference\n\nMerck (NYSE: MRK), known as MSD outside of the United States and Canada,\nannounced today that Dr. Marjorie Green, senior vice president and head of\noncology, global clinical development, Merck Research Laboratories, is\nscheduled to participate in a fireside chat at the Jefferies Global Healthcare\nConference on Thursday, June 4, 2026, at 10:30 a.m. ET.\n\nInvestors, analysts, members of the media and the general public are invited\nto listen to a live audio webcast of the presentation at this weblink\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fevent.summitcast.com%2Fview%2FNgCqua4VVQjq9ibVWHVWca%2FcpwJoJai4zfVTMG46iL7VW&esheet=54542772&newsitemid=20260528272528&lan=en-US&anchor=weblink&index=1&md5=c65caeb13de5fc26587436480cf6784c)\n.\n\nAbout Merck\n\nAt Merck, known as MSD outside of the United States and Canada, we are unified\naround our purpose: We use the power of leading-edge science to save and\nimprove lives around the world. For more than 130 years, we have brought hope\nto humanity through the development of important medicines and vaccines. We\naspire to be the premier research-intensive biopharmaceutical company in the\nworld – and today, we are at the forefront of research to deliver innovative\nhealth solutions that advance the prevention and treatment of diseases in\npeople and animals. We foster a diverse and inclusive global workforce and\noperate responsibly every day to enable a safe, sustainable and healthy future\nfor all people and communities. For more information, visit www.merck.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.merck.com%2F&esheet=54542772&newsitemid=20260528272528&lan=en-US&anchor=www.merck.com&index=2&md5=0641a1ea5ba385c81c0b43154c0144a8)\nand connect with us on X (formerly Twitter)\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Ftwitter.com%2FMerck&esheet=54542772&newsitemid=20260528272528&lan=en-US&anchor=X+%28formerly+Twitter%29&index=3&md5=a5c378156f205649560539a3821f8cda)\n, Facebook\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.facebook.com%2FMerckInvents%2F&esheet=54542772&newsitemid=20260528272528&lan=en-US&anchor=Facebook&index=4&md5=a37e89aeddac05e8d303e81e677095b1)\n, Instagram\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.instagram.com%2Fmerck%2F&esheet=54542772&newsitemid=20260528272528&lan=en-US&anchor=Instagram&index=5&md5=b211c13080ddfd46d0a7ed50132a8c31)\n, YouTube\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.youtube.com%2FMerck&esheet=54542772&newsitemid=20260528272528&lan=en-US&anchor=YouTube&index=6&md5=ef9ae5dc856d12d63c06d1436aa8c475)\nand LinkedIn\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fmerck&esheet=54542772&newsitemid=20260528272528&lan=en-US&anchor=LinkedIn&index=7&md5=b16cb569273c32b5e7831b416dd98290)\n.\n\nForward-Looking statement of Merck & Co., Inc., Rahway, N.J., USA\n\nThis news release of Merck & Co., Inc., Rahway, N.J., USA (the\n“company”) includes “forward-looking statements” within the meaning of\nthe safe harbor provisions of the U.S. Private Securities Litigation Reform\nAct of 1995. These statements are based upon the current beliefs and\nexpectations of the company’s management and are subject to significant\nrisks and uncertainties. If underlying assumptions prove inaccurate or risks\nor uncertainties materialize, actual results may differ materially from those\nset forth in the forward-looking statements.\n\nRisks and uncertainties include but are not limited to, general industry\nconditions and competition; general economic factors, including interest rate\nand currency exchange rate fluctuations; the impact of pharmaceutical industry\nregulation and health care legislation in the United States and\ninternationally; global trends toward health care cost containment;\ntechnological advances, new products and patents attained by competitors;\nchallenges inherent in new product development, including obtaining regulatory\napproval; the company’s ability to accurately predict future market\nconditions; manufacturing difficulties or delays; financial instability of\ninternational economies and sovereign risk; dependence on the effectiveness of\nthe company’s patents and other protections for innovative products; and the\nexposure to litigation, including patent litigation, and/or regulatory\nactions.\n\nThe company undertakes no obligation to publicly update any forward-looking\nstatement, whether as a result of new information, future events or otherwise.\nAdditional factors that could cause results to differ materially from those\ndescribed in the forward-looking statements can be found in the company’s\nAnnual Report on Form 10-K for the year ended December 31, 2025 and the\ncompany’s other filings with the Securities and Exchange Commission (SEC)\navailable at the SEC’s Internet site (www.sec.gov\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.sec.gov&esheet=54542772&newsitemid=20260528272528&lan=en-US&anchor=www.sec.gov&index=8&md5=15d86724c9c3c34bf5a1f09bb8cea0bb)\n).\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260528272528/en/\n(https://www.businesswire.com/news/home/20260528272528/en/)\n\nMedia Contacts:\n\n\n\nJohn Cummins\n\njohn.cummins2@merck.com \n(mailto:john.cummins2@merck.com) \n\n\nMichael Levey\n\nmichael.levey@merck.com (mailto:michael.levey@merck.com)\n\nInvestor Contacts:\n\n\n\nPeter Dannenbaum\n\n(732) 594-1579\n\n\n\nSteven Graziano\n\n(732) 594-1583\n\n\nCopyright Business Wire 2026"},"type":"article","timestamp":"2026-05-28T10:45:00.139765579Z","server_sent_at_ms":1779965100139},"received_at":"2026-05-28T10:45:00.258Z","source_url":"https://www.businesswire.com/news/home/20260528272528/en/"},"analysis":{"id":"36998","press_release_id":"47565","analysis_json":{"industry":{"label":"Pharmaceuticals, Biotechnology & Life Sciences","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"Merck announced that Dr. Marjorie Green, head of oncology global clinical development, will participate in a fireside chat at the Jefferies Global Healthcare Conference.\n\nThe event is scheduled for June 4, 2026, at 10:30 a.m. ET, with a live audio webcast available for investors and analysts.\n\nThe release contains no new operational or financial disclosures, serving only as a logistical notice for the upcoming investor event.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine conference notice -- no new material information."},"keyFigures":{},"quotedText":"Merck to Participate in the Jefferies Global Healthcare Conference","namedEntities":{"people":[{"name":"Dr. Marjorie Green","role":"Senior Vice President and Head of Oncology, Global Clinical Development"},{"name":"John Cummins","role":"Media Contact"},{"name":"Michael Levey","role":"Media Contact"},{"name":"Peter Dannenbaum","role":"Investor Contact"},{"name":"Steven Graziano","role":"Investor Contact"}],"products":[],"companies":[{"name":"Merck","ticker":"MRK","relationship":"filer"},{"name":"Jefferies","relationship":"conference organizer"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Routine conference participation announcement. No new financial data, guidance, or product milestones disclosed. Standard boilerplate corporate communication."},"tickerRelevance":{"others":[],"primary":"MRK"},"globalImportance":15,"audienceRelevance":25,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mega-cap","eventGravity":"conference-notice","issuerAuthored":true,"householdBrandBoost":true}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Merck announced that Dr. Marjorie Green, head of oncology global clinical development, will participate in a fireside chat at the Jefferies Global Healthcare Conference.\n\nThe event is scheduled for June 4, 2026, at 10:30 a.m. ET, with a live audio webcast available for investors and analysts.\n\nThe release contains no new operational or financial disclosures, serving only as a logistical notice for the upcoming investor event.","key_figures":{},"named_entities":{"people":[{"name":"Dr. Marjorie Green","role":"Senior Vice President and Head of Oncology, Global Clinical Development"},{"name":"John Cummins","role":"Media Contact"},{"name":"Michael Levey","role":"Media Contact"},{"name":"Peter Dannenbaum","role":"Investor Contact"},{"name":"Steven Graziano","role":"Investor Contact"}],"products":[],"companies":[{"name":"Merck","ticker":"MRK","relationship":"filer"},{"name":"Jefferies","relationship":"conference organizer"}],"dollarAmounts":[]},"model_name":"qwen3_6_27b_awq","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-05-28T10:46:01.467Z","global_importance":15,"audience_relevance":25,"importance_components":{"tickerTier":"mega-cap","eventGravity":"conference-notice","issuerAuthored":true,"householdBrandBoost":true}},"durationMs":61196,"modelName":"george-droid-qwen-72b"}}